Article
Author(s):
While leaders of both political parties say they want to provide Medicare patients with meaningful coverage for prescription drug expenses, major philosophical differences threaten to make that objective extremely difficult to achieve.
Patricia Farris, MD, on AP31’s Anti-Aging Power
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
First Patient Dosed in Phase 1 Study of Attovia's ATTO-1310 for Chronic Pruritus
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Developing an OTC Dermatology Product
Clinical Validation Reached in Phase 2a Trial of AX-158 for Psoriasis